Takeaway

• The addition of durvalumab to chemotherapy significantly improved OS in patients with advanced biliary tract cancer.

Why this matters

• Findings suggest that immunotherapy plus chemotherapy could potentially become a new standard of care for patients with advanced disease.

Study design

• In the multinational TOPAZ-1 trial, 365 patients with unresectable...